Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan
· Delayed Price · Currency is TWD 29.75
+0.40 (1.36%)
Mar 10, 2026, 12:39 PM CST
TPEX:4111 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,756 | 1,584 | 1,519 | 1,544 | 1,316 | 1,365 | Upgrade
|
| Market Cap Growth | 7.57% | 4.32% | -1.66% | 17.32% | -3.55% | -3.62% | Upgrade
|
| Enterprise Value | 1,360 | 1,313 | 1,268 | 1,425 | 1,261 | 1,093 | Upgrade
|
| Last Close Price | 29.35 | 25.69 | 23.73 | 23.07 | 18.87 | 18.70 | Upgrade
|
| PE Ratio | 10.69 | 14.32 | 22.11 | 10.03 | 16.30 | 23.08 | Upgrade
|
| PS Ratio | 1.29 | 1.36 | 1.43 | 1.35 | 1.29 | 1.39 | Upgrade
|
| PB Ratio | 1.31 | 1.24 | 1.25 | 1.26 | 1.20 | 1.27 | Upgrade
|
| P/TBV Ratio | 1.32 | 1.24 | 1.25 | 1.26 | 1.20 | 1.27 | Upgrade
|
| P/FCF Ratio | 11.84 | 12.28 | - | 14.10 | - | 11.23 | Upgrade
|
| P/OCF Ratio | 7.17 | 7.43 | 20.38 | 7.19 | 9.45 | 9.51 | Upgrade
|
| EV/Sales Ratio | 1.00 | 1.13 | 1.20 | 1.25 | 1.23 | 1.12 | Upgrade
|
| EV/EBITDA Ratio | 5.01 | 7.95 | 10.29 | 6.50 | 6.61 | 7.17 | Upgrade
|
| EV/EBIT Ratio | 7.04 | 13.27 | 20.71 | 9.26 | 10.60 | 14.46 | Upgrade
|
| EV/FCF Ratio | 9.17 | 10.18 | - | 13.01 | - | 8.99 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.10 | 0.11 | 0.13 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.09 | 0.16 | 1.00 | 0.57 | 0.73 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 0.17 | 0.21 | - | 1.17 | - | 0.10 | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.24 | -0.21 | -0.27 | -0.10 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.53 | -1.87 | -2.10 | -1.50 | -0.57 | -2.12 | Upgrade
|
| Net Debt / FCF Ratio | -2.67 | -2.40 | 9.57 | -2.99 | 0.86 | -2.66 | Upgrade
|
| Asset Turnover | 0.75 | 0.66 | 0.60 | 0.66 | 0.65 | 0.65 | Upgrade
|
| Inventory Turnover | 8.36 | 8.26 | 7.63 | 7.61 | 7.58 | 7.68 | Upgrade
|
| Quick Ratio | 1.62 | 1.83 | 1.57 | 1.54 | 1.20 | 2.00 | Upgrade
|
| Current Ratio | 1.90 | 2.11 | 1.78 | 1.78 | 1.46 | 2.34 | Upgrade
|
| Return on Equity (ROE) | 12.91% | 8.87% | 5.63% | 15.44% | 9.90% | 5.51% | Upgrade
|
| Return on Assets (ROA) | 6.68% | 3.52% | 2.15% | 5.56% | 4.73% | 3.14% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.90% | 8.25% | 5.19% | 16.31% | 11.15% | 7.02% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.50% | 7.20% | 4.70% | 11.70% | 9.80% | 6.30% | Upgrade
|
| Earnings Yield | 9.42% | 6.98% | 4.52% | 9.97% | 6.13% | 4.33% | Upgrade
|
| FCF Yield | 8.44% | 8.14% | -1.78% | 7.09% | -9.54% | 8.91% | Upgrade
|
| Dividend Yield | 3.17% | 3.71% | 4.01% | 4.95% | 5.05% | 5.09% | Upgrade
|
| Payout Ratio | - | 51.51% | 99.57% | 37.00% | 70.57% | 96.35% | Upgrade
|
| Buyback Yield / Dilution | -0.47% | -0.12% | 0.16% | -0.06% | -0.10% | 0.01% | Upgrade
|
| Total Shareholder Return | 2.70% | 3.59% | 4.17% | 4.89% | 4.95% | 5.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.